CL2004000552A1 - Procedimiento para la obtencion de un producto de reaccion alcaloide que comprende al menos un derivado de alcaloide que tiene un nitrogeno cuaternario; un producto de reaccion alcaloide; un derivado de quelidonina; y su uso para el tratamiento de in - Google Patents

Procedimiento para la obtencion de un producto de reaccion alcaloide que comprende al menos un derivado de alcaloide que tiene un nitrogeno cuaternario; un producto de reaccion alcaloide; un derivado de quelidonina; y su uso para el tratamiento de in

Info

Publication number
CL2004000552A1
CL2004000552A1 CL200400552A CL2004000552A CL2004000552A1 CL 2004000552 A1 CL2004000552 A1 CL 2004000552A1 CL 200400552 A CL200400552 A CL 200400552A CL 2004000552 A CL2004000552 A CL 2004000552A CL 2004000552 A1 CL2004000552 A1 CL 2004000552A1
Authority
CL
Chile
Prior art keywords
reaction product
alkaloid
derivative
alcaloid
procedure
Prior art date
Application number
CL200400552A
Other languages
English (en)
Spanish (es)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of CL2004000552A1 publication Critical patent/CL2004000552A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564Three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
CL200400552A 2003-03-18 2004-03-17 Procedimiento para la obtencion de un producto de reaccion alcaloide que comprende al menos un derivado de alcaloide que tiene un nitrogeno cuaternario; un producto de reaccion alcaloide; un derivado de quelidonina; y su uso para el tratamiento de in CL2004000552A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006015A EP1459753A1 (en) 2003-03-18 2003-03-18 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments

Publications (1)

Publication Number Publication Date
CL2004000552A1 true CL2004000552A1 (es) 2005-01-21

Family

ID=32798820

Family Applications (2)

Application Number Title Priority Date Filing Date
CL200400552A CL2004000552A1 (es) 2003-03-18 2004-03-17 Procedimiento para la obtencion de un producto de reaccion alcaloide que comprende al menos un derivado de alcaloide que tiene un nitrogeno cuaternario; un producto de reaccion alcaloide; un derivado de quelidonina; y su uso para el tratamiento de in
CL2008002345A CL2008002345A1 (es) 2003-03-18 2008-08-08 Compuesto derivado de quelidonina cuaternaria; procedimiento de preparacion; y su uso en la profilaxis o el tratamiento de una infeccion viral, cancer, disfuncion inmunologica, disfuncion metabolica y daño por radiacion. (divisional de la sol.552-04)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2008002345A CL2008002345A1 (es) 2003-03-18 2008-08-08 Compuesto derivado de quelidonina cuaternaria; procedimiento de preparacion; y su uso en la profilaxis o el tratamiento de una infeccion viral, cancer, disfuncion inmunologica, disfuncion metabolica y daño por radiacion. (divisional de la sol.552-04)

Country Status (36)

Country Link
US (1) US7795434B2 (enExample)
EP (2) EP1459753A1 (enExample)
JP (1) JP5303719B2 (enExample)
KR (1) KR101020680B1 (enExample)
CN (1) CN1532198A (enExample)
AR (1) AR043629A1 (enExample)
AT (1) ATE469651T1 (enExample)
AU (1) AU2004222661B2 (enExample)
BR (1) BRPI0408386A (enExample)
CA (1) CA2517769C (enExample)
CL (2) CL2004000552A1 (enExample)
CY (1) CY1112598T1 (enExample)
DE (1) DE602004027496D1 (enExample)
DK (1) DK1644012T3 (enExample)
EA (1) EA009049B1 (enExample)
ES (1) ES2346216T3 (enExample)
GE (1) GEP20084501B (enExample)
GT (1) GT200400046A (enExample)
HR (1) HRP20050987B1 (enExample)
IL (1) IL170505A (enExample)
MA (1) MA27833A1 (enExample)
MX (1) MXPA05009919A (enExample)
MY (1) MY141779A (enExample)
NO (1) NO333672B1 (enExample)
NZ (1) NZ542151A (enExample)
PA (1) PA8598201A1 (enExample)
PE (1) PE20050351A1 (enExample)
PL (1) PL1644012T3 (enExample)
PT (1) PT1644012E (enExample)
SG (1) SG158748A1 (enExample)
SI (1) SI1644012T1 (enExample)
TN (1) TNSN05230A1 (enExample)
TW (1) TWI347939B (enExample)
UA (1) UA89353C2 (enExample)
WO (1) WO2004082698A1 (enExample)
ZA (1) ZA200507020B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
WO2009148623A2 (en) 2008-06-05 2009-12-10 Stc.Unm Methods and related compositions for the treatment of cancer
CN102552264A (zh) * 2012-02-28 2012-07-11 苏州大学 血根碱在制备电离辐射防护剂中的应用
WO2021073603A1 (en) * 2019-10-17 2021-04-22 Chengdu Anticancer Bioscience, Ltd. Benzophenanthridine alkaloids and their methods of use
CN113372355B (zh) * 2021-05-13 2023-02-17 山东大学 六氢苯并菲啶类生物碱及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865830A (en) 1969-06-16 1975-02-11 Nikolai Mikhailovich Turkevich Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
SU368254A1 (ru) 1969-06-16 1973-01-26 А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт Способ получения соединений тиофосфамида с алкалоидами чистотела большого
AT354644B (de) 1975-12-19 1980-01-25 Nowicky Wassili Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) 1976-06-28 1985-05-28 Nowicky Wassili Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407833B (de) * 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
AT408719B (de) 2000-03-22 2002-02-25 Nowicky Wassili Mittel zur behandlung von hepatitis c
CH695417A5 (de) 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.

Also Published As

Publication number Publication date
TNSN05230A1 (en) 2007-06-11
NO20054130D0 (no) 2005-09-06
CA2517769A1 (en) 2004-09-30
GT200400046A (es) 2005-11-24
US7795434B2 (en) 2010-09-14
EP1644012B1 (en) 2010-06-02
NO333672B1 (no) 2013-08-05
EA200501473A1 (ru) 2006-02-24
TW200505467A (en) 2005-02-16
JP5303719B2 (ja) 2013-10-02
AR043629A1 (es) 2005-08-03
GEP20084501B (en) 2008-10-10
JP2006520763A (ja) 2006-09-14
EP1644012A1 (en) 2006-04-12
PA8598201A1 (es) 2004-11-26
US20060154947A1 (en) 2006-07-13
DE602004027496D1 (de) 2010-07-15
AU2004222661A1 (en) 2004-09-30
MY141779A (en) 2010-06-30
UA89353C2 (uk) 2010-01-25
CY1112598T1 (el) 2016-02-10
PL1644012T3 (pl) 2011-01-31
PE20050351A1 (es) 2005-05-04
DK1644012T3 (da) 2010-10-04
ATE469651T1 (de) 2010-06-15
EP1459753A1 (en) 2004-09-22
BRPI0408386A (pt) 2006-03-21
AU2004222661B2 (en) 2008-10-02
KR20060010726A (ko) 2006-02-02
KR101020680B1 (ko) 2011-03-09
HRP20050987A2 (en) 2007-07-31
CL2008002345A1 (es) 2009-01-02
TWI347939B (en) 2011-09-01
CA2517769C (en) 2012-09-25
ZA200507020B (en) 2006-11-29
CN1532198A (zh) 2004-09-29
HRP20050987B1 (hr) 2014-03-28
NO20054130L (no) 2005-12-19
EA009049B1 (ru) 2007-10-26
WO2004082698A1 (en) 2004-09-30
SI1644012T1 (sl) 2010-10-29
NZ542151A (en) 2008-11-28
MA27833A1 (fr) 2006-04-03
IL170505A (en) 2013-04-30
PT1644012E (pt) 2010-07-29
ES2346216T3 (es) 2010-10-13
MXPA05009919A (es) 2006-03-21
SG158748A1 (en) 2010-02-26

Similar Documents

Publication Publication Date Title
SG139762A1 (en) Lithographic apparatus and method for calibrating the same
EP1608281A4 (en) DEVICE AND METHOD FOR EXACTLY LIMITED CRYOABLATION
DE60305374T8 (de) Insassenbeinschutzvorrichtung
DE60140784D1 (de) Organische elektrolumineszente vorrichtung und verfahren zu dessen herstellung
BR0209866B1 (pt) aparelho e mÉtodo de retenÇço para uso em uma cabeÇa de poÇo e conjunto de cabeÇa de poÇo.
FI20011421L (fi) Menetelmä ja laite toiminnon toteuttamiseksi
GB0330257D0 (en) Nitrogen inerting system
GB0509625D0 (en) Method and apparatus for searching
TWI366931B (en) Organic laser apparatus
IL155757A0 (en) Method and device for the generation of cyclopropene compounds
FI20021078A7 (fi) Menetelmä ja laitteisto levymäisten kuitulujitteisten tuotteiden valmistamiseksi
GB0617959D0 (en) Part positioning method and device for the method
EP1614186A4 (en) METHOD AND DEVICE FOR GENERATING MULTIPLE RAYS
ITAR20020029A0 (it) Rivelatore di metalli e procedimento di verifica per il medesimo
CL2004000552A1 (es) Procedimiento para la obtencion de un producto de reaccion alcaloide que comprende al menos un derivado de alcaloide que tiene un nitrogeno cuaternario; un producto de reaccion alcaloide; un derivado de quelidonina; y su uso para el tratamiento de in
FI20021005L (fi) Irrokepaperin pohjapaperi ja menetelmä sen valmistamiseksi
FI20030446L (fi) Artikkelin irrotuslaite ja menetelmä sellaisen käyttämiseksi
DE60307582D1 (de) Insassenbeinschutzvorrichtung
ITMI20030178A1 (it) Apparecchiatura e procedimento di fissaggio/ritenuta
GB2416850B (en) Method and device for security searches
DE50209942D1 (de) Vorrichtung zum verriegeln eines längsbeweglich geführten bauteiles
PL378224A1 (pl) Sposób, urządzenie oraz układ do okresowego znakowania obiektów
GB0510727D0 (en) Client and method for database
DE50301909D1 (de) Stufenlos blockierbare Feststellvorrichtung
FI20010241L (fi) Puun 3-vaiheinen kuivausmenetelmä ja siinä tarvittava laitteisto